rs767199
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000103.4(CYP19A1):c.-38-5240C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.373 in 152,094 control chromosomes in the GnomAD database, including 12,521 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.37 ( 12521 hom., cov: 32)
Consequence
CYP19A1
NM_000103.4 intron
NM_000103.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.790
Publications
17 publications found
Genes affected
CYP19A1 (HGNC:2594): (cytochrome P450 family 19 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.496 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CYP19A1 | NM_000103.4 | c.-38-5240C>T | intron_variant | Intron 1 of 9 | ENST00000396402.6 | NP_000094.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.373 AC: 56678AN: 151976Hom.: 12521 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
56678
AN:
151976
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.373 AC: 56679AN: 152094Hom.: 12521 Cov.: 32 AF XY: 0.371 AC XY: 27584AN XY: 74358 show subpopulations
GnomAD4 genome
AF:
AC:
56679
AN:
152094
Hom.:
Cov.:
32
AF XY:
AC XY:
27584
AN XY:
74358
show subpopulations
African (AFR)
AF:
AC:
5501
AN:
41510
American (AMR)
AF:
AC:
5178
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
1761
AN:
3468
East Asian (EAS)
AF:
AC:
2146
AN:
5170
South Asian (SAS)
AF:
AC:
1491
AN:
4818
European-Finnish (FIN)
AF:
AC:
5225
AN:
10576
Middle Eastern (MID)
AF:
AC:
104
AN:
292
European-Non Finnish (NFE)
AF:
AC:
33993
AN:
67962
Other (OTH)
AF:
AC:
807
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1653
3307
4960
6614
8267
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
534
1068
1602
2136
2670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1011
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.